Production (Stage)
TG Therapeutics, Inc.
TGTX
$35.16
-$0.08-0.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.68% | 42.98% | 48.82% | 49.93% | 50.16% |
| Total Receivables | 192.57% | 152.84% | 194.32% | 378.20% | 653.59% |
| Inventory | 102.99% | 177.37% | 152.34% | 168.71% | 185.51% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 151.88% | 65.10% | 91.03% | -55.82% | -12.29% |
| Total Current Assets | 78.74% | 78.13% | 79.89% | 86.58% | 95.14% |
|
|
|||||
| Total Current Assets | 78.74% | 78.13% | 79.89% | 86.58% | 95.14% |
| Net Property, Plant & Equipment | -13.11% | -11.17% | -11.82% | -11.73% | -10.69% |
| Long-term Investments | -- | -- | -- | -- | 0.00% |
| Goodwill | -- | -- | -- | -- | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 26.18% | -6.18% | 23.96% | 23.11% | -6.98% |
| Total Assets | 75.90% | 75.28% | 77.01% | 81.66% | 89.16% |
|
|
|||||
| Total Accounts Payable | 29.84% | -10.16% | 128.91% | 21.52% | 30.94% |
| Total Accrued Expenses | 42.72% | 24.75% | 20.95% | -4.37% | 11.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.72% | 0.83% | -25.44% | 11.57% | -7.79% |
| Total Finance Division Other Current Liabilities | 167.93% | 352.36% | 161.89% | 435.56% | 684.78% |
| Total Other Current Liabilities | 167.93% | 352.36% | 161.89% | 435.56% | 684.78% |
| Total Current Liabilities | 60.72% | 68.80% | 116.92% | 49.54% | 58.04% |
|
|
|||||
| Total Current Liabilities | 60.72% | 68.80% | 116.92% | 49.54% | 58.04% |
| Long-Term Debt | 141.53% | 144.14% | 146.85% | 4.95% | 5.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.28% | -11.89% | -11.58% | -11.32% | -11.10% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 103.39% | 100.88% | 8,408.42% | 1,534.50% | 1,114.98% |
| Total Liabilities | 96.70% | 110.15% | 136.84% | 23.97% | 25.48% |
|
|
|||||
| Common Stock & APIC | 5.41% | 2.76% | 4.93% | 4.81% | 5.74% |
| Retained Earnings | 0.06% | 1.51% | -3.51% | 3.56% | 2.63% |
| Treasury Stock & Other | -6,360.26% | -3,743.59% | -918.38% | 0.00% | 0.00% |
| Total Common Equity | 48.20% | 38.54% | 16.62% | 338.95% | 483.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.20% | 38.54% | 16.62% | 338.95% | 483.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.20% | 38.54% | 16.62% | 338.95% | 483.64% |
|
|
|||||